CA SB1258

Expands CURES (Controlled Substance Utilization Review and Evaluation System) monitoring to include Schedule V controlled substances, requiring reporting of prescribing and dispensing information to the Department of Justice.

Requires electronic prescriptions for controlled substances starting January 1, 2016 (January 1, 2017 for medical practices with two or fewer physicians and providers in underserved rural areas), in compliance with Drug Enforcement Administration regulations.

Authorizes investigators designated by professional licensing boards to access CURES patient data to investigate alleged substance abuse by licensees, requiring probable cause documentation in the application.

Limits controlled substance prescriptions to a 30-day supply maximum, with exceptions allowing up to 90-day supplies for specific conditions including panic disorder, chronic pain, ADHD, narcolepsy, and movement disorders, plus physician-determined medical necessities.

Prohibits prescribing new controlled substance prescriptions within 30 days of a previous prescription for the same substance unless the patient has exhausted all but a 7-day supply from the prior prescription.